EP 2094697 A1 20090902 - 5-SULFANYLMETHYL-PYRAZOLO [1,5-A]PYRIMIDIN-7-OL DERIVATIVES AS CXCR2 ANTAGONISTS
Title (en)
5-SULFANYLMETHYL-PYRAZOLO [1,5-A]PYRIMIDIN-7-OL DERIVATIVES AS CXCR2 ANTAGONISTS
Title (de)
5-SULFANYLMETHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-OLDERIVATE ALS CXCR2 ANTAGONISTEN
Title (fr)
DERIVES DE 5-SULFANYLMETHYL-PYRAZOLO[1,5-A]PYRIMIDIN-7-OL UTILISES EN TANT QU'ANTAGONISTES DU CXCR2
Publication
Application
Priority
- EP 2007062662 W 20071121
- EP 06124682 A 20061123
- EP 07822797 A 20071121
Abstract (en)
[origin: WO2008062026A1] The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.
IPC 8 full level
A61K 31/522 (2006.01); A61P 29/00 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP KR US)
A61K 31/522 (2013.01 - KR); A61P 11/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 471/04 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2008062026A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008062026 A1 20080529; AU 2007324472 A1 20080529; BR PI0718956 A2 20131217; CA 2669579 A1 20080529; CN 101573359 A 20091104; EP 2094697 A1 20090902; JP 2010510291 A 20100402; KR 20090082424 A 20090730; MX 2009005358 A 20090605; US 2010152205 A1 20100617
DOCDB simple family (application)
EP 2007062662 W 20071121; AU 2007324472 A 20071121; BR PI0718956 A 20071121; CA 2669579 A 20071121; CN 200780043628 A 20071121; EP 07822797 A 20071121; JP 2009537636 A 20071121; KR 20097010525 A 20071121; MX 2009005358 A 20071121; US 51473207 A 20071121